Key result
Nitric oxide synthesis blockade with L-NAME increases canine arterial pressure by ~22%.
The goal of this study was to determine if there is a basal release of nitric oxide that affects long-term arterial pressure regulation in dogs. Studies were conducted over a 23-day period in eight conscious dogs with indwelling catheters. Nitric oxide synthesis was blocked by continuous intravenous infusion of nitro-L-arginine-methyl ester at 37.1 nmol/kg per minute for 11 days. Arterial pressure increased to 120 +/- 4% of control on the first day, decreased for a few days, and then increased to a maximum value of 122 +/- 6% of control on day 7. Bradycardia was sustained throughout the entire nitro-arginine period. Blockade of nitric oxide synthesis was evidenced by attenuated pressure and flow responses to systemic acetylcholine infusion. The pressor response to phenylephrine was increased for only 1 day, and the hypotensive effects of nitroprusside were enhanced. Also, the variability of arterial pressure was significantly increased during nitro-arginine. Sodium and water balances were positive the first day of nitro-arginine infusion but were unchanged for the entire nitro-arginine period. In conclusion, the data suggest that blockade of the basal release of nitric oxide in dogs causes an increase in the long-term level of arterial pressure without any sustained sodium or water retention.
No takes yet. Share an insight, caveat, or question.
Manning et al. (1993) studied Long-term arterial pressure regulation (n=8). Nitro-L-arginine-methyl ester (L-NAME) vs. Baseline control period was evaluated on Arterial pressure (% of control). Long-term nitric oxide synthesis blockade with nitro-L-arginine-methyl ester in dogs increased arterial pressure to 120±4% of control on day 1 and a maximum of 122±6% on day 7.
Synapse has enriched 5 related papers. Consider them for comparative context: